Literature DB >> 8829174

Vitamin E inhibits proliferation of human Tenon's capsule fibroblasts in vitro.

A L Haas1, D Boscoboinik, D S Mojon, M Böhnke, A Azzi.   

Abstract

Failure of glaucoma surgery is mostly due to fibrocellular scar formation, derived from Tenon's capsule fibroblasts. In high-risk cases, postoperative Tenon's capsule fibroblast proliferation is inhibited by mitomycin C or 5-fluorouracil. Toxicity to other ocular cell types and the risk of ocular hypotony limits the use of these agents. We have found that d-alpha-tocopherol (vitamin E) was able to inhibit proliferation of in vitro human Tenon's capsule fibroblasts obtained from seven different donors. At 48 h, inhibition of cell proliferation was 30-78% (mean 60%) for 50 microM d-alpha-tocopherol and 46-97% (mean 77%) for 100 microM d-alpha-tocopherol. This inhibition was statistically significant. No cytotoxic effects were observed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8829174     DOI: 10.1159/000267899

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  8 in total

1.  Collagen type I and III synthesis by Tenon's capsule fibroblasts in culture: individual patient characteristics and response to mitomycin C, 5-fluorouracil, and ascorbic acid.

Authors:  R L Gross
Journal:  Trans Am Ophthalmol Soc       Date:  1999

2.  Inhibition of bovine RPE cells by vitamin E succinate.

Authors:  D Mojon; D Boscoboinik; A Haas; M Böhnke; A Azzi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-03       Impact factor: 3.117

3.  Tocotrienol inhibits proliferation of human Tenon's fibroblasts in vitro: a comparative study with vitamin E forms and mitomycin C.

Authors:  Alexander Meyenberg; David Goldblum; Jean-Marc Zingg; Angelo Azzi; Kalanithi Nesaretnam; Monika Kilchenmann; Beatrice E Frueh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-05-21       Impact factor: 3.117

4.  Vitamin E prevents changes in the cornea and conjunctiva due to vitamin A deficiency.

Authors:  Azusa Fujikawa; Huaqing Gong; Tsugio Amemiya
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-03-15       Impact factor: 3.117

5.  Antifibrotic effects of tocotrienols on human Tenon's fibroblasts.

Authors:  Christoph Tappeiner; Alexander Meyenberg; David Goldblum; Daniel Mojon; Jean-Marc Zingg; Kalanithi Nesaretnam; Monika Kilchenmann; Beatrice E Frueh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-08-14       Impact factor: 3.117

6.  Rationale of combination therapy with antioxidants in medical management of Peyronie's disease: results of clinical application.

Authors:  Gianni Paulis; Andrea Paulis; Gennaro Romano; Davide Barletta; Andrea Fabiani
Journal:  Res Rep Urol       Date:  2017-07-20

Review 7.  Recent Pathophysiological Aspects of Peyronie's Disease: Role of Free Radicals, Rationale, and Therapeutic Implications for Antioxidant Treatment-Literature Review.

Authors:  Gianni Paulis; Gennaro Romano; Luca Paulis; Davide Barletta
Journal:  Adv Urol       Date:  2017-07-04

Review 8.  Alpha-tocopherol: looking beyond an antioxidant.

Authors:  Kaya Nusret Engin
Journal:  Mol Vis       Date:  2009-04-23       Impact factor: 2.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.